There are currently 403 clinical trials in Scottsdale, Arizona looking for participants to engage in research studies. Trials are conducted at various facilities, including Mayo Clinic in Arizona, Mayo Cliinic - Scottsdale, Mayo Clinic and Mayo Clinic Arizona. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors
NCT05601219
Recruiting
This study consists of dose escalation evaluation to determine the safety and tolerability of ADA-011 as a monotherapy and in combination with a checkpoint inhibitor. Following dose escalation, one or more dose expansion cohorts in selected indications will be explored to further evaluate the safety, tolerability, and preliminary efficacy of ADA-011.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/07/2023
Locations: HonorHealth, Scottsdale, Arizona
Conditions: Solid Tumor, Adult
Register for Updates
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT03961945
Recruiting
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
11/01/2023
Locations: Mayo Clinic Arizona, Scottsdale, Arizona
Conditions: Barrett Esophagus, Esophageal Adenocarcinoma
Register for Updates
Exploring Cultural Acceptability of Community Breast Cancer Risk Assessment Among Hispanic Women in Maricopa County
NCT06112795
Recruiting
This study explores the cultural acceptability of community breast cancer risk assessment among Hispanic women in Maricopa county.
Gender:
Female
Ages:
Between 40 years and 65 years
Trial Updated:
10/31/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Breast Carcinoma, Breast Cancer, Breast Cancer Female
Register for Updates
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
NCT05053100
Recruiting
This study evaluates the risks and experience of blood clots and bleeding in patients with blood cancers. While it is standard of care to use medications to reduce the risk of blood clots in hospitalized individuals, some patients with blood cancers have low platelet counts that can increase the concern for bleeding complications associated with these medications. At this time, the optimal management strategies for blood clots are not well known for patients with blood cancers. This pilot study... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Acute Leukemia, Deep Vein Thrombosis, Hematopoietic and Lymphoid Cell Neoplasm, Hodgkin Lymphoma, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Thrombocytopenia
Register for Updates
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
NCT05094804
Recruiting
This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR2805 administered as a monotherapy and in combination with anti-cancer agents in subjects with advanced solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: HonorHealth Research Institute, Scottsdale, Arizona
Conditions: Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer, Melanoma, Head and Neck Squamous Cell Carcinoma, Leiomyosarcoma, Liposarcoma
Register for Updates
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
NCT02810704
Recruiting
PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.
Gender:
All
Ages:
21 years and above
Trial Updated:
10/30/2023
Locations: Mayo Clinic, Scottsdale, Arizona
Conditions: Pulmonary Embolism, Venous Thrombosis
Register for Updates
Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer
NCT05417867
Recruiting
This pilot study seeks to understand how changes in the bacteria composition (microbiome) of the gut may be associated with the occurrence of chemotherapy-induced nausea (CIN) in women undergoing chemotherapy for stage I-III breast cancer. Patients undergoing chemotherapy may experience nausea as a result of their treatment. Known risk factors for CIN do not explain the differences in CIN occurrence between patients, but changes in the functions of the gut microbiome may be related to the occurr... Read More
Gender:
All
Ages:
20 years and above
Trial Updated:
10/26/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Chemotherapy-Related Nausea and/or Vomiting, Early Stage Breast Carcinoma
Register for Updates
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT06008392
Recruiting
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in "real world" practice conditions.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/26/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Cancer, Cancer Gene Mutation, PAN Gene Mutation
Register for Updates
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)
NCT06055881
Recruiting
This study assesses if metastasis-directed radiation therapy (Stereotactic body radiation therapy - SBRT) can delay a change in systemic therapy, and if circulating tumor cells in the bloodstream can help guide treatment options in metastatic breast cancer patients with progressive disease.
Gender:
Female
Ages:
18 years and above
Trial Updated:
10/24/2023
Locations: Mayo Clinic in Arizona, Scottsdale, Arizona
Conditions: Breast Carcinoma
Register for Updates
Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention
NCT05826587
Recruiting
The purpose of this research is to see if taking part in a structured exercise plan that is designed to improve balance and muscle strength and one that can done at home helps to improve the ability to perform standard physical tasks, confidence in balance, and health-related quality-of-life
Gender:
All
Ages:
18 years and above
Trial Updated:
10/20/2023
Locations: Mayo Clinic Arizona, Scottsdale, Arizona
Conditions: Cardiac Rehabilitation
Register for Updates
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
NCT05766813
Recruiting
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a diagnosis of Parkinson's Disease consistent with the UK Parkinson's Disease Society (UKPDS) Brain Bank diagnostic criteria, who are experiencing wearing off symptoms and levodopa-induced dyskinesia.
Gender:
All
Ages:
Between 40 years and 80 years
Trial Updated:
10/20/2023
Locations: Clinical Site, Scottsdale, Arizona
Conditions: Parkinson Disease
Register for Updates
Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
NCT05068752
Recruiting
The purpose of this research is to determine the benefit of two oral chemotherapy drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
10/18/2023
Locations: HonorHealth Research Institute, Scottsdale, Arizona
Conditions: Pancreas Cancer
Register for Updates